UBS Group’s Apollomics APLM Stock Holding History

UBS Group’s Portfolio APLM Stock Details APLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42	Sell	2 -140	-99%	-$2.12K	﹤0.01%	10213
2026 Q1	$2.25K	Buy	142 +78	+122%	+$1.52K	﹤0.01%	9309
2025 Q4	$1.2K	Buy	64 +48	+300%	+$881	﹤0.01%	9662
2025 Q3	$295	Sell	16 -7,267	-100%	-$45.4K	﹤0.01%	9756
2025 Q2	$47.8K	Buy	7,283 +4,936	+210%	+$30.3K	﹤0.01%	7811
2025 Q1	$14.6K	Buy	2,347 +2,174	+1,257%	+$18.2K	﹤0.01%	8422
2024 Q4	$1.69K	Sell	173 -1,142	-87%	-$13.3K	﹤0.01%	9183
2024 Q3	$18.7K	Buy	+1,315	New	+$21.1K	﹤0.01%	7411
2024 Q2	–	Sell	-75	Closed	-$5.63K	–	9489
2024 Q1	$5.63K	Sell	75 -246	-77%	-$18.5K	﹤0.01%	7523
2023 Q4	$31K	Buy	+321	New	+$39.5K	﹤0.01%	6827
2023 Q2	–	Sell	-4	Closed	-$10K	–	8869
2023 Q1	$10K	Buy	+4	New	+$10.7K	﹤0.01%	7615

Other funds holding APLM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group's APLM Position: Q2 2026 in Review

UBS Group reduced its Apollomics (APLM) stake by 99% in Q2 2026, selling an estimated $2.12K and leaving 2 shares worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #10213.

UBS Group first reported a position in APLM in Q1 2023 and has held it in 11 quarters since. The position peaked at $47.8K in Q2 2025. 3 funds tracked by Wall St. Rank hold APLM as of Q2 2026.

UBS Group held 2 shares of Apollomics worth $42 as of Q2 2026.
UBS Group sold 140 Apollomics shares in Q2 2026, an estimated $2.12K.
Apollomics made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10213 holding.
UBS Group first reported a position in Apollomics in Q1 2023 and has held it in 11 quarters since.
UBS Group's Apollomics position peaked at $47.8K in Q2 2025.
3 funds tracked by Wall St. Rank held Apollomics as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.